Vertiv Holdings: The Market Is Making The Same Mistake Twice, Still A Buy
Source: seekingalpha.com

Vertiv reported Q2 2026 adjusted EPS up 60% YoY and raised full-year guidance, with deferred revenue doubling—signals of demand strength. However, shares sold off as revenue timing missed expectations, despite management projecting ~40% YoY Q3 revenue growth and citing NVIDIA-linked integration expanding thermal and power solutions. Valuation multiples cited were 38.16x 2026E EPS and 28.13x 2027E EPS, with management aiming for ~60% earnings compounding.
Analysis
The market is reacting to a sequencing issue as if it were a demand issue. In AI infrastructure, revenue timing misses often reflect shipment/billing cadence, while rising deferred revenue and prepayments tell you customers are still reserving capacity; that is more consistent with a supply-constrained vendor than a deteriorating end market. Over the next 1-2 quarters, the key question is conversion rate, not order intake.
Vertiv’s positioning at the thermal/power bottleneck makes it a higher-quality way to express the AI capex cycle than the accelerator names themselves. If NVIDIA remains the load driver, the ecosystem can absorb more GPU deployments only if rack-level power and cooling keep pace, which should keep VRT’s backlog quality high and reduce substitution risk versus smaller, undifferentiated electrical suppliers. PSIX could see some secondary interest from on-site generation demand, but that is a slower, less visible catalyst and depends more on grid/interconnect constraints than on AI adoption alone.
The contrarian risk is valuation: a stock compounding this fast can still de-rate hard if revenue growth normalizes below the market’s embedded path. At current multiples, even a modest hiccup in the next 1-2 quarters could compress the forward P/E by 15-20%, so the selloff is only a buy if management sustains ~35-40% revenue growth and avoids margin slippage. Falsifier: any reduction in the next quarter’s revenue guide or evidence that deferred revenue is not converting into recognized sales on schedule.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.10
Ticker Sentiment
Key Decisions for Investors
- Long VRT on post-earnings weakness over a 1-3 month horizon; treat the selloff as a timing dislocation, not a demand break, but only if the stock holds its post-print support and management keeps Q3 growth guidance intact.
- Use VRT as the cleaner AI infrastructure expression versus NVDA for this specific theme; prefer VRT if the objective is to capture power/cooling bottlenecks rather than GPU upside.
- Relative-value watch: underweight PSIX until there is evidence that behind-the-meter generation is being spec'd into AI campuses at scale; otherwise the catalyst is too indirect and slower than the VRT conversion story.
- Set a falsification trigger on the next quarterly print: if revenue growth comes in materially below the implied 35-40% run-rate or deferred revenue stalls, cut exposure and expect multiple compression.
More News
- Faced with less compute and fewer tokens, Chinese AI labs are tightening the gap with the U.S. by just being more efficient
- French AI boom exposes Europe’s funding gap as startups turn to U.S.
- Is Lululemon Nearing Its Bottom?
- Wall Street Analyst Sees Between 19% to 37% Upside in These 5 AI Chip Stocks
- Nvidia may put $10bn into Anthropic’s IPO, more than Europe’s largest AI round in full
- Oracle's AI Chips Ran 97.9% Utilized Last Quarter. For Nvidia, That Is What a Shortage Looks Like.